share_log

NIO, Lucid Group And Other Big Gainers From Monday

NIO, Lucid Group And Other Big Gainers From Monday

蔚来、Lucid Group等周一起大涨
Benzinga Real-time News ·  2022/09/13 03:01

U.S. stocks closed higher with the Dow Jones surging more than 200 points on Monday. Here is the list of some big stocks moving higher in the previous session.

美国股市周一收盘走高，道琼斯指数飙升超过200点。以下是前一交易日走高的一些大型股的名单。

  • Ventyx Biosciences, Inc. (NASDAQ:VTYX) shares climbed 65% to close at $38.11 on Monday after Oppenheimer maintained an Outperform rating on the stock and raised its price target from $40 to $65.
  • IHS Holding Limited (NYSE:IHS) gained 24.9% to close at $7.83. IHS Holding, last month, said Q2 EPS results down year-over-year.
  • Asana, Inc. (NYSE:ASAN) rose 16.4% to close at $28.71. Asana's President, CEO and Director Dustin Moskovitz bought a total of 19,273,127 shares at an average price of $18.16.
  • Carvana Co. (NYSE:CVNA) rose 15.5% to close at $42.28. Piper Sandler upgraded Carvana from Neutral to Overweight and lowered the price target from $98 to $73.
  • NIO Inc. (NYSE:NIO) surged 13.5% to close at $21.75 after Deutsche Bank reportedly reiterated the stock as a top China pick.
  • SpringWorks Therapeutics, Inc. (NASDAQ:SWTX) rose 12.8% to close at $31.98 after the company announced data from the Phase 3 DeFi trial of nirogacestat in adult patients with desmoid tumors showed nirogacestat treatment resulted in rapid, sustained and statistically significant improvements in primary and all key secondary efficacy endpoints.
  • Sigma Lithium Corporation (NASDAQ:SGML) gained 11.4% to close at $27.81.
  • Montauk Renewables, Inc. (NASDAQ:MNTK) jumped 10.7% to close at $20.16.
  • Lucid Group, Inc. (NASDAQ:LCID) jumped 9.7% to close at $16.55 after RF Lafferty initiated coverage on the stock with a Buy rating and a $19 price target.
  • NetScout Systems, Inc. (NASDAQ:NTCT) rose 9.4% to close at $33.60. The company, last month, posted upbeat quarterly earnings.
  • 5E Advanced Materials Inc. (NASDAQ:FEAM) jumped 9.3% to settle at $18.14.
  • TAL Education Group (NYSE:TAL) gained 9.1% to close at $5.89.
  • Sprinklr, Inc. (NYSE:CXM) jumped 8.1% to close at $13.29 after the company last week reported better-than-expected Q2 results and issued strong guidance.
  • Wayfair Inc. (NYSE:W) gained 7.7% to settle at $55.95 amid overall market strength as investors await this week's inflation data.
  • Bristol-Myers Squibb Company (NYSE:BMY) gained 3.1% to settle at $72.36. The FDA approved Bristol Myers Squibb Co's Sotyktu (deucravacitinib), an allosteric tyrosine kinase 2 (TYK2) inhibitor, for moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy. Atlantic Equities maintained Bristol-Myers Squibb with an Overweight and raised the price target from $83 to $87.
  • 文蒂克斯生物科学公司纳斯达克(Sequoia Capital：VTYX)股价周一攀升65%，收于38.11美元，此前奥本海默维持对该股的强于大盘的评级，并将目标价从40美元上调至65美元。
  • IHS控股有限公司(纽约证券交易所代码：IHS)上涨24.9%，收于7.83美元。上个月，IHS Holding表示，第二季度每股收益同比下降。
  • 阿莎娜股份有限公司(纽约证券交易所代码：ASAN)上涨16.4%，收于28.71美元。阿莎娜的首席执行官总裁和董事首席执行官达斯汀·莫斯科维茨以18.16美元的平均价格购买了19,273,127股票。
  • Carvana Co.(纽约证券交易所代码：CVNA)上涨15.5%，收于42.28美元。Piper Sandler将Carvana评级从中性上调至增持，并将目标价从98美元下调至73美元。
  • 蔚来。蔚来(NYSE：Tmall)暴涨13.5%，收于21.75美元，此前有报道称，德意志银行重申该股为中国首选。
  • SpringWorks治疗公司纳斯达克(纳斯达克股票代码：SWTX)上涨12.8%，收于31.98美元，此前该公司宣布，在成年硬纤维瘤患者中进行的尼罗西坦3期DEFI试验数据显示，尼罗西坦治疗导致主要和所有关键次要疗效终点的快速、持续和统计上的显著改善。
  • 西格玛锂公司纳斯达克(Sequoia Capital：SGML)上涨11.4%，收于27.81美元。
  • 蒙托克可再生能源公司纳斯达克(Sequoia Capital：MNTK)跳涨10.7%，收于20.16美元。
  • Lucid Group公司纳斯达克(Kleiner Perkins Caufield&Byers)股价上涨9.7%，收于16.55美元，此前RF Lafferty对该股的评级为买入，目标价为19美元。
  • NetScout系统公司纳斯达克(Standard Chartered Bank：NTCT)上涨9.4%，收于33.6美元。上个月，该公司公布了乐观的季度收益。
  • 5E先进材料公司纳斯达克(Sequoia Capital：FEAM)跳涨9.3%，报18.14美元。
  • 好未来(纽约证券交易所代码：TAL)上涨9.1%，收于5.89美元。
  • 斯普林克勒股份有限公司纽约证券交易所股票代码：CXM)跳涨8.1%，收于13.29美元，该公司上周公布的第二季度业绩好于预期，并发布了强劲的指引。
  • WayFair Inc.(纽约证券交易所股票代码：W)上涨7.7%，收于55.95美元，整体市场走强，投资者等待本周的通胀数据。
  • 百时美施贵宝公司(纽约证券交易所代码：BMY)上涨3.1%，收于72.36美元。FDA批准百时美施贵宝公司的Sotyktu(Deucravisitinib)，一种变构酪氨酸激酶2(TYK2)抑制剂，用于治疗中到重度斑块型牛皮癣，这些牛皮癣适合系统治疗或光疗。大西洋证券维持百时美施贵宝的增持，并将目标价从83美元上调至87美元。
声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发